journal article·2022-06Open access

Encoding with a fluorescence-activating and absorption-shifting tag generates living bacterial probes for mammalian microbiota imaging

Zhenping Cao, Lu Wang, Rui Liu, Sisi Lin, Feng Wu, Jinyao Liu

Abstract

The mammalian microbiota plays essential roles in health. A primary determinant to understand the interaction with the host is the distribution and viability of its key microorganisms. Here, a strategy of encoding with a fluorescence-activating and absorption-shifting tag (FAST) is reported to prepare living bacterial probes for real-time dynamic, dual-modal, and molecular oxygen-independent imaging of the host microbiota. Carrying FAST endows bacteria with rapid on-demand turn on-off fluorescence by adding or removal of corresponding fluorogens. Encoded bacteria are able to reversibly switch emission bands for dual-color fluorescence imaging via fluorogen exchange. Due to molecular oxygen-independent emission of FAST, encoded bacteria can emit fluorescence under anaerobic environments including the gut and tumor. These living probes demonstrate the applicability to quantify the vitality of bacteria transplanted to the gut microbiota. This work proposes a unique fluorescence probe for investigating the dynamics of the host microbiota.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Cancer Research and Treatments · Bacteriophages and microbial interactions · Gut microbiota and health

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (60)

Show source-provided references
1. Dissecting the interplay mechanism between epigenetics and gut microbiota: health maintenance and disease prevention10.3390/ijms22136933 ↗
2. Human gut microbiome: function matters10.1016/j.tim.2017.11.002 ↗
3. Emerging pathogenic links between microbiota and the gut-lung axis10.1038/nrmicro.2016.142 ↗
4. Literature mapping: association of microscopic skin microflora and biomarkers with macroscopic skin health10.1111/ced.14353 ↗
5. The microbiome, cancer, and cancer therapy10.1038/s41591-019-0377-7 ↗
6. The tumor microbiome in pancreatic cancer: bacteria and beyond10.1016/j.ccell.2019.11.004 ↗
7. Gut microbiota in human metabolic health and disease10.1038/s41579-020-0433-9 ↗
8. Host-microbiota interactions in immune-mediated diseases10.1038/s41579-020-0367-2 ↗
9. A gut bacterial pathway metabolizes aromatic amino acids into nine circulating metabolites10.1038/nature24661 ↗
10. Skin microbiota-host interactions10.1038/nature25177 ↗
11. Gut microbiota modulation of chemotherapy efficacy and toxicity10.1038/nrgastro.2017.20 ↗
12. Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease
13. The role of the intestinal microbiota in type 1 diabetes mellitus10.1038/nrendo.2015.218 ↗
14. Microbiota, obesity and NAFLD10.1007/978-981-10-8684-7_9 ↗
15. Next generation sequencing of microbial transcriptomes: challenges and opportunities10.1111/j.1574-6968.2009.01767.x ↗
16. Tumor microbiome diversity and composition influence pancreatic cancer outcomes10.1016/j.cell.2019.07.008 ↗
17. Highly multiplexed spatial mapping of microbial communities10.1038/s41586-020-2983-4 ↗
18. Photoactive yellow protein and its chemical probes: an approach to protein labelling in living cells10.1093/jb/mvz051 ↗
19. Sequence-specific end labeling of oligonucleotides (SSELO)-Based microbial detection10.1007/978-1-4939-9000-9_4 ↗
20. Imaging commensal microbiota and pathogenic bacteria in the gut10.1021/acs.accounts.1c00068 ↗
21. Three-dimensional quantitative imaging of native microbiota distribution in the gut10.1002/anie.202010921 ↗
22. Synthesis of fluorescent D-amino acids and their use for probing peptidoglycan synthesis and bacterial growth in situ10.1038/nprot.2014.197 ↗
23. Assessing the viability of transplanted gut microbiota by sequential tagging with D-amino acid-based metabolic probes10.1038/s41467-019-09267-x ↗
24. Fluorogenic D-amino acids enable real-time monitoring of peptidoglycan biosynthesis and high-throughput transpeptidation assays10.1038/s41557-019-0217-x ↗
25. Labeling nuclear DNA using DAPI
26. Labeling nuclear DNA with hoechst 33342
27. Influence of the membrane dye R18 and of DMSO on cell penetration of guanidinium-rich peptides10.1002/cbdv.201800302 ↗
28. Metabolic labeling of peptidoglycan with NIR-II dye enables in vivo imaging of gut microbiota10.1002/anie.201910555 ↗
29. A novel in vivo cell-wall labeling approach sheds new light on peptidoglycan synthesis in Escherichia coli10.1002/cbic.201000552 ↗
30. Imaging peptidoglycan biosynthesis in Bacillus subtilis with fluorescent antibiotics10.1073/pnas.0600829103 ↗
31. Near-infrared fluorescent proteins and their applications
32. Acoustic reporter genes for noninvasive imaging of microorganisms in mammalian hosts10.1038/nature25021 ↗
33. Application of the red fluorescent protein mCherry in mycelial labeling and organelle tracing in the dermatophyte Trichophyton mentagrophytes
34. Chemogenetic tags with probe exchange for live-cell fluorescence microscopy10.1021/acschembio.1c00100 ↗
35. Engineering and characterization of a superfolder green fluorescent protein10.1038/nbt1172 ↗
36. Green fluorescent protein10.1111/j.1751-1097.1995.tb08712.x ↗
37. Small fluorescence-activating and absorption-shifting tag for tunable protein imaging in vivo10.1073/pnas.1513094113 ↗
38. Fluorescent proteins for live cell imaging: opportunities, limitations, and challenges10.1002/iub.256 ↗
39. Protein tagging and detection with engineered self-assembling fragments of green fluorescent protein10.1038/nbt1044 ↗
40. Green fluorescent protein: structure, folding and chromophore maturation10.1039/b903641p ↗
41. High variation of fluorescence protein maturation times in closely related Escherichia coli strains10.1371/journal.pone.0075991 ↗
42. Fluorescent proteins: maturation, photochemistry and photophysics10.1016/j.sbi.2006.10.001 ↗
43. Dynamic multicolor protein labeling in living cells10.1039/C7SC01364G ↗
44. Orthogonal fluorescent chemogenetic reporters for multicolor imaging10.1038/s41589-020-0611-0 ↗
45. Production of the biocommodities butanol and acetone from methanol with fluorescent FAST-tagged proteins using metabolically engineered strains of Eubacterium limosum10.1186/s13068-021-01966-2 ↗
46. Escherichia coli Nissle 1917 (Mutaflor): new insights into an old probiotic bacterium10.1159/000333307 ↗
47. Genetic engineering of probiotic Escherichia coli Nissle 1917 for clinical application10.1007/s00253-016-7829-5 ↗
48. Genetic engineering of host organisms for pharmaceutical synthesis10.1016/j.copbio.2018.02.001 ↗
49. A far-red emitting fluorescent chemogenetic reporter for in vivo molecular imaging10.1002/anie.202006576 ↗
50. Programmable and printable Bacillus subtilis biofilms as engineered living materials10.1038/s41589-018-0169-2 ↗
51. Conformable self-assembling amyloid protein coatings with genetically programmable functionality10.1126/sciadv.aba1425 ↗
52. Living materials fabricated via gradient mineralization of light-inducible biofilms10.1038/s41589-020-00697-z ↗
53. Immobilization of functional nano-objects in living engineered bacterial biofilms for catalytic applications10.1093/nsr/nwz104 ↗
54. Spatial organization of a model 15-member human gut microbiota established in gnotobiotic mice10.1073/pnas.1711596114 ↗
55. A strongly fluorescing anaerobic reporter and protein-tagging system for Clostridium organisms based on the fluorescence-activating and absorption-shifting tag protein (FAST)10.1128/AEM.00622-19 ↗
56. Interactions between the microbiota, immune and nervous systems in health and disease10.1038/nn.4476 ↗
57. Escherichia coli Nissle 1917 as a novel microrobot for tumor-targeted imaging and therapy10.3390/pharmaceutics13081226 ↗
58. Fecal microbiota transplantation in metabolic syndrome: history, present and future10.1080/19490976.2017.1293224 ↗
59. Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients10.1126/science.abb5920 ↗
60. A probiotic spore-based oral autonomous nanoparticles generator for cancer therapy10.1002/adma.201903793 ↗